• Clinical Insights: December 29, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Gemtesa® (vibegron) Tablets – New Drug Approval – December 23, 2020 – Urovant Sciences announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug… Read more »

  • Clinical Insights: December 22, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OrgovyxTM (relugolix) Tablets – New Drug Approval – December 18, 2020 – Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that… Read more »

  • Clinical Insights: December 15, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OrladeyoTM (berotralstat) Capsules – New Orphan Drug Approval – December 3, 2020 – BioCryst Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved oral,… Read more »

  • Clinical Insights: December 8, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Gallium 68 PSMA-11 (Ga 68 PSMA-11)  – New Drug Approval – December 1, 2020 – The U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11)… Read more »

  • Clinical Insights: December 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Imcivree®  (setmelanotide) Injection – New Drug Approval – November 27, 2020 – The U.S. Food and Drug Administration approved Imcivree®  (setmelanotide) for chronic weight management (weight loss and… Read more »

  • Clinical Insights: November 17, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets – New Drug Approval – November 10, 2020 – Sebela Pharmaceuticals® announced that the U.S. Food and Drug Administration… Read more »

  • Clinical Insights: November 10, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval SesquientTM (fosphenytoin sodium) Injection – New Drug Approval – November 5, 2020 – Sedor Pharmaceuticals, LLC announced that the U.S. Food and Drug Administration (FDA) has approved SesquientTM… Read more »

  • Clinical Insights: November 4, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Bronchitol® (mannitol) Inhalation Powder – New Drug Approval – October 30, 2020 – Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group… Read more »

  • Clinical Insights: October 27, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Veklury® (remdesivir) Injection – New Drug Approval – October 22, 2020 – The U.S. Food and Drug Administration approved the antiviral drug Veklury® (remdesivir) for use in adult… Read more »

  • Clinical Insights: October 20, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn) Injection – New Drug Approval – October 14, 2020 – The U.S. Food and Drug Administration approved InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn), a… Read more »